P4.05 POLYCYSTIN DEFICIENCY RESULTS IN COMPLETE LOSS OF NO SYNTHESIS DURING SUSTAINED FLOW-MEDIATED DILATATION OF CONDUIT ARTERIES IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: POSSIBLE REVERSAL BY DOPAMINE
Objectives: Autosomal dominant polycystic kidney disease (ADPKD) is due to mutations in genes PKD1 and PKD2 encoding polycystin-1 and -2, which transduce flow variations into cellular signals in the renal epithelium but also in vascular endothelium. However, the impact of polycystin deficiency on th...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Atlantis Press
2013-11-01
|
Series: | Artery Research |
Online Access: | https://www.atlantis-press.com/article/125939021/view |
id |
doaj-cb2a46650cc145418a9d5407a85393e6 |
---|---|
record_format |
Article |
spelling |
doaj-cb2a46650cc145418a9d5407a85393e62020-11-25T03:16:25ZengAtlantis PressArtery Research 1876-44012013-11-0171010.1016/j.artres.2013.10.124P4.05 POLYCYSTIN DEFICIENCY RESULTS IN COMPLETE LOSS OF NO SYNTHESIS DURING SUSTAINED FLOW-MEDIATED DILATATION OF CONDUIT ARTERIES IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: POSSIBLE REVERSAL BY DOPAMINEA. LorthioirR. JoannidèsI. Rémy-JouetC. Fréguin-BouillandM. IacobC. MonteilD. LucasM.P. AudrezetD. GuerrotV. RichardC. ThuillezM. GodinJ. BellienObjectives: Autosomal dominant polycystic kidney disease (ADPKD) is due to mutations in genes PKD1 and PKD2 encoding polycystin-1 and -2, which transduce flow variations into cellular signals in the renal epithelium but also in vascular endothelium. However, the impact of polycystin deficiency on the release of endothelium-derived factors during flow variations is unknown. Methods: In 21 normotensive ADPKD patients with normal kidney function and 21 control subjects, radial artery diameter and blood flow were measured during hand skin heating and post-ischemic hyperaemia. Local blood samples were drawn during heating to quantify plasma nitrite, indicator of nitric oxide (NO) availability, epoxyeicosatrienoic acids (EETs) and endothelin-1. Results: Basal inflammatory and oxidative stress markers were similar between groups. Flow-mediated dilatation was lower in ADPKD patients than in controls during heating (16.1±1.1 vs. 23.2±1.0%), as confirmed by their downward shift of the diameter-shear stress relationship, but not during post-ischemic hypaeremia, and without difference in endothelium-independent dilatation to glyceryl trinitrate. Nitrite increased during heating in controls but not in patients (30±10 vs. −16±8 nmol/L). Plasma EETs tended to increase in controls but not in patients, without difference in endothelin-1 reduction. Intra-brachial infusion of dopamine (0.25–0.5 mg/kg/min) during heating induced a dose-dependent upward shift of the diameter-shear stress relationship in ADPKD patients and restoration of NO release. Conclusions: ADPKD patients display a loss of NO release and subsequent reduction in endothelium-dependent dilatation during sustained flow increase. The prevention of this alteration by dopamine may help to reduce the high prevalence of cardiovascular diseases in ADPKD.https://www.atlantis-press.com/article/125939021/view |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
A. Lorthioir R. Joannidès I. Rémy-Jouet C. Fréguin-Bouilland M. Iacob C. Monteil D. Lucas M.P. Audrezet D. Guerrot V. Richard C. Thuillez M. Godin J. Bellien |
spellingShingle |
A. Lorthioir R. Joannidès I. Rémy-Jouet C. Fréguin-Bouilland M. Iacob C. Monteil D. Lucas M.P. Audrezet D. Guerrot V. Richard C. Thuillez M. Godin J. Bellien P4.05 POLYCYSTIN DEFICIENCY RESULTS IN COMPLETE LOSS OF NO SYNTHESIS DURING SUSTAINED FLOW-MEDIATED DILATATION OF CONDUIT ARTERIES IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: POSSIBLE REVERSAL BY DOPAMINE Artery Research |
author_facet |
A. Lorthioir R. Joannidès I. Rémy-Jouet C. Fréguin-Bouilland M. Iacob C. Monteil D. Lucas M.P. Audrezet D. Guerrot V. Richard C. Thuillez M. Godin J. Bellien |
author_sort |
A. Lorthioir |
title |
P4.05 POLYCYSTIN DEFICIENCY RESULTS IN COMPLETE LOSS OF NO SYNTHESIS DURING SUSTAINED FLOW-MEDIATED DILATATION OF CONDUIT ARTERIES IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: POSSIBLE REVERSAL BY DOPAMINE |
title_short |
P4.05 POLYCYSTIN DEFICIENCY RESULTS IN COMPLETE LOSS OF NO SYNTHESIS DURING SUSTAINED FLOW-MEDIATED DILATATION OF CONDUIT ARTERIES IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: POSSIBLE REVERSAL BY DOPAMINE |
title_full |
P4.05 POLYCYSTIN DEFICIENCY RESULTS IN COMPLETE LOSS OF NO SYNTHESIS DURING SUSTAINED FLOW-MEDIATED DILATATION OF CONDUIT ARTERIES IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: POSSIBLE REVERSAL BY DOPAMINE |
title_fullStr |
P4.05 POLYCYSTIN DEFICIENCY RESULTS IN COMPLETE LOSS OF NO SYNTHESIS DURING SUSTAINED FLOW-MEDIATED DILATATION OF CONDUIT ARTERIES IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: POSSIBLE REVERSAL BY DOPAMINE |
title_full_unstemmed |
P4.05 POLYCYSTIN DEFICIENCY RESULTS IN COMPLETE LOSS OF NO SYNTHESIS DURING SUSTAINED FLOW-MEDIATED DILATATION OF CONDUIT ARTERIES IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: POSSIBLE REVERSAL BY DOPAMINE |
title_sort |
p4.05 polycystin deficiency results in complete loss of no synthesis during sustained flow-mediated dilatation of conduit arteries in autosomal dominant polycystic kidney disease: possible reversal by dopamine |
publisher |
Atlantis Press |
series |
Artery Research |
issn |
1876-4401 |
publishDate |
2013-11-01 |
description |
Objectives: Autosomal dominant polycystic kidney disease (ADPKD) is due to mutations in genes PKD1 and PKD2 encoding polycystin-1 and -2, which transduce flow variations into cellular signals in the renal epithelium but also in vascular endothelium. However, the impact of polycystin deficiency on the release of endothelium-derived factors during flow variations is unknown.
Methods: In 21 normotensive ADPKD patients with normal kidney function and 21 control subjects, radial artery diameter and blood flow were measured during hand skin heating and post-ischemic hyperaemia. Local blood samples were drawn during heating to quantify plasma nitrite, indicator of nitric oxide (NO) availability, epoxyeicosatrienoic acids (EETs) and endothelin-1.
Results: Basal inflammatory and oxidative stress markers were similar between groups. Flow-mediated dilatation was lower in ADPKD patients than in controls during heating (16.1±1.1 vs. 23.2±1.0%), as confirmed by their downward shift of the diameter-shear stress relationship, but not during post-ischemic hypaeremia, and without difference in endothelium-independent dilatation to glyceryl trinitrate. Nitrite increased during heating in controls but not in patients (30±10 vs. −16±8 nmol/L). Plasma EETs tended to increase in controls but not in patients, without difference in endothelin-1 reduction. Intra-brachial infusion of dopamine (0.25–0.5 mg/kg/min) during heating induced a dose-dependent upward shift of the diameter-shear stress relationship in ADPKD patients and restoration of NO release.
Conclusions: ADPKD patients display a loss of NO release and subsequent reduction in endothelium-dependent dilatation during sustained flow increase. The prevention of this alteration by dopamine may help to reduce the high prevalence of cardiovascular diseases in ADPKD. |
url |
https://www.atlantis-press.com/article/125939021/view |
work_keys_str_mv |
AT alorthioir p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine AT rjoannides p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine AT iremyjouet p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine AT cfreguinbouilland p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine AT miacob p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine AT cmonteil p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine AT dlucas p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine AT mpaudrezet p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine AT dguerrot p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine AT vrichard p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine AT cthuillez p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine AT mgodin p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine AT jbellien p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine |
_version_ |
1724636261756436480 |